SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as its community rallies around the OG meme coin, emphasizing its unique culture and strong presence across social platforms like TikTok and X. The community is focused on building and expanding the reach of $RAGE, highlighting its potential to lead the next memecoin cycle and bring back meme culture to web3. Bullish sentiment is fueled by the belief in its community-driven value and potential for significant growth.

On Solana, there’s only one way to have a true multi million dollar runner…. we all have to buy the same coin.

Same Coin

The crypto 'SAME' is trending as social media mentions surge, with many users coordinating efforts to purchase the coin. Community members highlight the ticker name itself, along with its recent listing on ST, as reasons for optimism. Some users are suggesting coordinated buying.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as traders speculate about potential catalysts ahead of the upcoming earnings release. Community members are actively discussing the possibility of a short squeeze and referencing past events, while some highlight the company's strong balance sheet.

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) Public Ltd Co - Ordinary Shares - Class A

SMX is trending due to a recent surge, fueled by news of partnerships and a perceived low float, leading to speculation of a potential gamma squeeze. Community discussions revolve around its volatile price action, potential for further gains, and the risk of a possible offering. Some traders are pointing to a reset of Dubai's gold market as a potential catalyst.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending amid community discussion around a potential short squeeze and government backing, sparked by the CFO's warning to short sellers. Traders are also pointing to the end of the year deadline for the Biden government's report on Polymetalic nodule refining process. The community is closely watching for potential news and catalysts that could drive the stock higher.

Copart, Inc. engages in the provision of online auctions and vehicle remarketing services. The firm offers vehicle sellers a full range of services to process and sell vehicles primarily over the internet through Virtual Bidding Third Generation Internet auction-style sales technology. It sells vehicles principally to licensed vehicle dismantlers, rebuilders, repair licensees, used vehicle dealers, exporters and at certain locations, and the public. The company’s services include online seller access, salvage estimation services, estimating services, end-of-life vehicle processing, virtual insured exchange, transportation services, vehicle inspection stations, on-demand reporting, DMV processing, and vehicle processing programs. It operates through the United States and International segments. The company was founded by Willis J. Johnson in 1982 and is headquartered in Dallas, TX.

Copart, Inc.

Copart, Inc. is trending as investors assess its growth potential amid discussions around rising operating expenses and competition. The community is weighing strong earnings, analyst ratings, and historical resilience against softening used car demand and potential market share losses. AI's increasing role in vehicle assessment, fraud detection, and customer service is also being discussed as a potential catalyst.

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

CME Group Inc - Ordinary Shares - Class A

CME Group Inc

CME Group is trending due to a cooling malfunction at a Chicago-area data center, causing a temporary halt to futures and options trading and triggering concerns about system resilience. Options activity and analyst ratings adjustments are also contributing to the conversation, with community members weighing in on the potential impact of the outage and long-term opportunities for the company amid market volatility and expansion into new sectors like crypto derivatives and prediction markets. The community is also actively discussing various options alerts and strategies.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as precious metals experience volatility, with community members debating if it's a temporary pullback or a sign of a larger correction. Discussions include possible manipulation and the impact of economic data, while longer-term bulls remain confident in silver's potential due to supply constraints and industrial demand. Some traders are focusing on the cup and handle pattern, expecting a breakout soon.

Baby Wojak

Baby Wojak ($BOWJAK) is gaining traction as a newly launched token on the Solana blockchain via Pump.fun, with the community drawing comparisons to Wojak ($WOJAK). Investors are actively discussing its potential as the 'next big runner' and sharing contract addresses.

Chagee Holdings Ltd. engages in the sales of freshly-made tea drinks, related raw materials, packaging, teahouse equipment, and other supplies. Its products include tea latte, teapuccino, iced oriental tea, teaspresso, and other creative tea drinks. The company was founded by Jun Jie Zhang in June 2017 and is headquartered in Shanghai, China.

Chagee Holdings Ltd. - ADR

Chagee ($CHA) is trending due to mixed sentiment around recent earnings and an upcoming dividend, sparking debates about its current valuation. The stock's volatility, coupled with its China-based IPO status, has investors weighing potential risks and rewards. Community members are actively discussing analyst ratings, potential for a short squeeze, and expansion plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IFRX Everyone ready for a hit of the obvious… 
 
People heal at different rates.  Yes, let it be known that there’s nothing magical about 6 months to perfection. 
 
The more one’s comorbidities, or as I like to think of it – the more one’s chronic inflammation – longer is their PG ulcer healing. 
 
“While further efforts are needed to establish standardized methods for detecting and addressing underlying conditions that might affect healing outcomes in PG, our results emphasize the need for implementing proactive comorbidity management along with therapeutic interventions in improving treatment outcomes.” 
 
CD11b expression measures anyone?  Vilo for longer, continuing the sustained trend towards 100% ulcer closure, there’s some practicality to be thinking about. 
 
https://pmc.ncbi.nlm.nih.gov/articles/PMC12640798/

Jana Klar

BIOVIC

CIELO1

FlowerInTheCellar

Stph

Robert Artur

Lydia Fikus

Charlene Richmond

avalon E

Pyoderma gangrenosum (PG) is a neutrophilic ulcerative dermatosis marked by increased healthcare utilization and delayed healing outcomes.1 Our previous research has shown that a history of thromboembolism prolongs healing time among PG patients.2 However, despite PG's recognized association with other systemic diseases, the impact of these comorbidities on PG-related healing outcomes remains unexplored.

PubMed Central (PMC)

Effects of Comorbidities on Delayed Wound Healing in Patients with Pyoderma Gangrenosum

StockTwits Web

InflaRx N.V.

 Everyone ready for a hit of the obvious… 
 
People heal at different rates.  Yes, let it be known that there’s nothing magical about 6 months to perfection. 
 
The more one’s comorbidities, or as I like to think of it – the more one’s chronic inflammation – longer is their PG ulcer healing. 
 
“While further efforts are needed to establish standardized methods for detecting and addressing underlying conditions that might affect healing outcomes in PG, our results emphasize the need for implementing proactive comorbidity management along with therapeutic interventions in improving treatment outcomes.” 
 
CD11b expression measures anyone?  Vilo for longer, continuing the sustained trend towards 100% ulcer closure, there’s some practicality to be thinking about. 
 


Is PG a neutrophilic – lots and lots of active neutrophils – dermatosis or isn’t it? 
 
Does Vilo safely and sufficiently block the primary signaling that activates neutrophils or not??????? 
 
Going on 6 months since study stop for all the wrong reasons. 
 
Let’s get on with it!

@MrCompassion is this the report we have been waiting for??? The results look fantastic! Do you agree?

StockTwits for iOS

 is this the report we have been waiting for??? The results look fantastic! Do you agree?

@MrCompassion Hello. 
 
I&#39;ve included a link. You might find it interesting. I can&#39;t judge it because I lack medical knowledge. 
 
https://ichgcp.net/ko/clinical-trials-registry/publications/282546-immune-signatures-predict-development-of-autoimmune-toxicity-in-patients-with-cancer-treated-with

Ichgcp

 Hello. 
 
I've included a link. You might find it interesting. I can't judge it because I lack medical knowledge. 
 


@FlowerInTheCellar Thanks.  Paper is about cancer treatment with drugs that bring more T cells to the tumor fighting party, though this can lead to an inflammatory response that may cause adverse events.  It was why I thought the Keytruda+Vilo study had a shot.  Worth redoing such a study, this time with INF904, for the added benefit of intracellular effect because of the small molecule design. 
 
Cancer treatment is as much an inflammatory disease as any other, a drug needed to help the immune system in that regard, not harm it further.

 Thanks.  Paper is about cancer treatment with drugs that bring more T cells to the tumor fighting party, though this can lead to an inflammatory response that may cause adverse events.  It was why I thought the Keytruda+Vilo study had a shot.  Worth redoing such a study, this time with INF904, for the added benefit of intracellular effect because of the small molecule design. 
 
Cancer treatment is as much an inflammatory disease as any other, a drug needed to help the immune system in that regard, not harm it further.

@MrCompassion Thanks for your effort. 
 
Yes, I remember the collaboration. I just don&#39;t know how it could have been medically beneficial, theoretically. It was discontinued, at least officially.

 Thanks for your effort. 
 
Yes, I remember the collaboration. I just don't know how it could have been medically beneficial, theoretically. It was discontinued, at least officially.